GNPX Stock News

Popular stocks:

Suncor Energy

TOP Stocks:

Shares of other companies:

Genprex (GNPX) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (06:51)

Sector: Healthcare

The share price of Genprex, Inc. (GNPX) now

What analysts predict: $8

52-week High/Low: $1.94 / $0.19

50/200 Day Moving Average: $0.314 / $0.721

This figure corresponds to the Average Price over the previous 50/200 days. For Genprex stocks, the 50-day moving average is the resistance level today.

For Genprex stocks, the 200-day moving average is the resistance level today.

Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2023, 2024, 2025, 2026, 2027. How much will one Genprex share be worth in 2023 - 2027?

When should I take profit in Genprex stock? When should I record a loss on Genprex stock? What are analysts' forecasts for Genprex stock? What is the future of Genprex stock? We forecast Genprex stock performance using neural networks based on historical data on Genprex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Genprex stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Genprex shares. This happens once a day.

Historical and forecast chart of Genprex stock

The chart below shows the historical price of Genprex stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Genprex stock price can be found in the table below.

Long-term forecasts by years.

Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).

Genprex daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 05	0.25	0.24	0.25	5.30
Dec 06	0.25	0.24	0.26	6.58
Dec 07	0.24	0.24	0.25	5.13
Dec 08	0.24	0.23	0.24	3.16
Dec 09	0.24	0.23	0.24	3.77
Dec 10	0.24	0.23	0.24	3.63
Dec 11	0.24	0.23	0.24	3.04
Dec 12	0.24	0.23	0.24	3.92
Dec 13	0.23	0.23	0.24	2.95
Dec 14	0.24	0.23	0.24	6.62
Dec 15	0.23	0.23	0.24	4.12
Dec 16	0.23	0.22	0.23	4.56
Dec 17	0.23	0.23	0.24	3.80
Dec 18	0.24	0.24	0.25	4.84
Dec 19	0.24	0.24	0.25	3.36
Dec 20	0.25	0.25	0.26	4.63
Dec 21	0.26	0.25	0.26	3.26
Dec 22	0.27	0.26	0.27	3.43
Dec 23	0.27	0.26	0.27	4.68
Dec 24	0.27	0.27	0.28	4.15
Dec 25	0.27	0.26	0.27	3.00
Dec 26	0.26	0.26	0.27	6.18
Dec 27	0.26	0.25	0.27	6.81
Dec 28	0.25	0.25	0.26	4.33
Dec 29	0.26	0.25	0.26	5.30
Dec 30	0.27	0.26	0.27	6.20
Dec 31	0.26	0.25	0.26	3.91
Jan 01	0.26	0.26	0.27	4.23
Jan 02	0.26	0.25	0.26	6.00
Jan 03	0.25	0.24	0.25	3.94

Genprex Daily Price Targets

Genprex Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $0.25.
Positive dynamics for Genprex shares will prevail with possible volatility of 5.034%.
Pessimistic target level: 0.24
Optimistic target level: 0.25

Genprex Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $0.25.
Positive dynamics for Genprex shares will prevail with possible volatility of 6.170%.
Pessimistic target level: 0.24
Optimistic target level: 0.26

Genprex Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $0.24.
Negative dynamics for Genprex shares will prevail with possible volatility of 4.877%.
Pessimistic target level: 0.24
Optimistic target level: 0.25

Genprex Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.24.
Negative dynamics for Genprex shares will prevail with possible volatility of 3.062%.
Pessimistic target level: 0.23
Optimistic target level: 0.24

Genprex Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.24.
Negative dynamics for Genprex shares will prevail with possible volatility of 3.637%.
Pessimistic target level: 0.23
Optimistic target level: 0.24

Genprex Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.24.
Negative dynamics for Genprex shares will prevail with possible volatility of 3.501%.
Pessimistic target level: 0.23
Optimistic target level: 0.24

GNPX (GNPX) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Dec.	0.23	0.21	0.26	19.94

Full forecast for 2023

Genprex forecast for this year

Genprex Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $0.233462. Pessimistic: $0.21. Optimistic: $0.26

Genprex (GNPX) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.26	0.24	0.29	17.12
Feb	0.28	0.25	0.32	21.32
Mar	0.27	0.25	0.29	13.75
Apr	0.26	0.25	0.29	14.33
May	0.25	0.22	0.26	16.74
Jun	0.23	0.22	0.24	7.40
Jul	0.24	0.22	0.27	17.93
Aug	0.22	0.20	0.23	13.14
Sep	0.20	0.19	0.22	14.31
Oct	0.20	0.19	0.21	8.04
Nov	0.21	0.20	0.23	10.86
Dec	0.21	0.19	0.23	19.80

Full forecast for 2024

Genprex (GNPX) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.21	0.20	0.23	10.78
Feb	0.24	0.22	0.25	12.09
Mar	0.24	0.22	0.25	12.99
Apr	0.25	0.22	0.26	16.51
May	0.24	0.21	0.25	15.95
Jun	0.24	0.23	0.26	11.44
Jul	0.25	0.22	0.28	19.60
Aug	0.25	0.22	0.25	11.78
Sep	0.25	0.23	0.28	17.64
Oct	0.27	0.24	0.30	19.82
Nov	0.30	0.28	0.33	14.98
Dec	0.32	0.28	0.36	20.09

Full forecast for 2025

Genprex (GNPX) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.34	0.32	0.35	7.57
Feb	0.31	0.28	0.34	15.41
Mar	0.31	0.30	0.33	8.83
Apr	0.30	0.27	0.33	17.45
May	0.29	0.27	0.31	14.01
Jun	0.29	0.27	0.30	11.26
Jul	0.33	0.30	0.34	12.09
Aug	0.37	0.32	0.41	20.06
Sep	0.35	0.32	0.38	14.16
Oct	0.37	0.35	0.40	10.39
Nov	0.37	0.36	0.40	11.76
Dec	0.38	0.36	0.39	8.72

Full forecast for 2026

Genprex (GNPX) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.38	0.33	0.39	14.81
Feb	0.43	0.38	0.47	18.77
Mar	0.44	0.41	0.48	14.41
Apr	0.37	0.34	0.39	14.46
May	0.36	0.33	0.37	10.20
Jun	0.39	0.36	0.40	10.23
Jul	0.41	0.37	0.44	16.11
Aug	0.47	0.45	0.49	9.33
Sep	0.48	0.44	0.54	18.09
Oct	0.55	0.50	0.61	18.99
Nov	0.55	0.53	0.60	11.13
Dec	0.56	0.50	0.60	16.67

Full forecast for 2027

Genprex information and performance

Genprex Address

100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US

Market Capitalization: 16 641 700 $

Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.

EBITDA: -31 650 372 $

EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.61

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.332

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 59435000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

PainReform Ltd. (PRFX)

Clover Health Investments, Corp. (CLOV)

Clever Leaves Holdings Inc. (CLVR)

UnitedHealth Group, Inc. (UNH)

MultiPlan Corp. (MPLN)

Progenity, Inc. (PROG)

Edwards Lifesciences Corp. (EW)

ImmunityBio, Inc. (IBRX)

Mesoblast Limited (MESO)

Aridis Pharmaceuticals, Inc. (ARDS)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/GNPX.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/GNPX.svg"> Genprex (GNPX) Stock Forecast for 2023 – 2026. Sell or Buy?